EP3204375
Spíróindólín til meðferðar við og til að fyrirbyggja RS-veirusýkingu í öndunarvegum (RSV)
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
6.10.2015EP published:
13.2.2019EP application number:
15782033.3
EP translation filed:
5.3.2019Grant published:
15.5.2019EPO information:
European Patent Register
Max expiry date:
5.10.2035Expiry date:
5.10.2026Next due date:
31.10.2026
Title:
SPIRO-INDOLINES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION (RSV)
Timeline
Today
6.10.2015EP application
13.2.2019EP Publication
5.3.2019Translation submitted
15.5.2019Registration published
5.10.2026Expires
Owner
Name:
Pfizer Inc.Address:
66 Hudson Boulevard East, New York, NY 10001-2192, US
Inventor
Name:
COCKERILL, StuartAddress:
Stevenage SG1 2FX, GB
Name:
MATHEWS, NeilAddress:
Stevenage SG1 2FX, GB
Name:
WARD, SimonAddress:
CardiffCF10 3AT, GB
Name:
LUNN, GrahamAddress:
BrightonEast Sussex BN1 9RH, GB
Name:
PARADOWSKI, MichaelAddress:
BrightonEast Sussex BN1 9RH, GB
Name:
GASCON SIMORTE, Jose MiguelAddress:
BrightonEast Sussex BN1 9RH, GB
Agent
Name:
Tego ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201417707Date:
7.10.2014Country:
GB
Classification
Categories:
C07D 401/06, C07D 471/10, A61K 31/437, A61P 31/14
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 9.9.2019
Expires: 5.10.2020
Payer: Árnason Faktor
Number: 6
Paid: 9.9.2020
Expires: 5.10.2021
Payer: Árnason Faktor ehf.
Number: 7
Paid: 7.9.2021
Expires: 5.10.2022
Payer: Árnason Faktor ehf.
Number: 8
Paid: 27.10.2022
Expires: 5.10.2023
Payer: Árnason Faktor ehf.
Number: 9
Paid: 25.9.2023
Expires: 5.10.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 8.10.2024
Expires: 5.10.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 8.10.2025
Expires: 5.10.2026
Payer: Árnason Faktor ehf.